Search results
It's Probably Less Likely That G1 Therapeutics, Inc.'s (NASDAQ:GTHX) CEO Will See A Huge Pay Rise...
Simply Wall St. via Yahoo Finance· 3 days agoKey Insights G1 Therapeutics will host its Annual General Meeting on 13th of June Total pay for CEO...
G1 Therapeutics (GTHX) Reports Q3 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoG1 Therapeutics (GTHX) delivered earnings and revenue surprises of 7.81% and 4.14%, respectively,...
G1 Therapeutics, Inc.'s (NASDAQ:GTHX) Shares Lagging The Industry But So Is The Business
Simply Wall St. via Yahoo Finance· 1 year agoG1 Therapeutics, Inc.'s (NASDAQ:GTHX) price-to-sales (or "P/S") ratio of 2.8x might make it look...
G1 Therapeutics, Inc. (NASDAQ:GTHX) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 months agoG1 Therapeutics, Inc. (NASDAQ:GTHX) Q4 2023 Earnings Call Transcript February 28, 2024 G1...
Will G1 Therapeutics (GTHX) Report Negative Earnings Next Week? What You Should Know
Zacks via Yahoo Finance· 8 months agoG1 Therapeutics (GTHX) doesn't possess the right combination of the two key ingredients for a likely...
G1 Therapeutics, Inc.'s (NASDAQ:GTHX) top owners are individual investors with 46% stake, while 38%...
Simply Wall St. via Yahoo Finance· 10 months agoKey Insights Significant control over G1 Therapeutics by individual investors implies that the...
G1 Therapeutics (GTHX) Moves to Buy: Rationale Behind the Upgrade
Zacks via Yahoo Finance· 1 year agoG1 Therapeutics (GTHX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about...
G1 Therapeutics, Inc.'s (NASDAQ:GTHX) 47% loss last week hit both individual investors who own 60%...
Simply Wall St. via Yahoo Finance· 4 months agoKey Insights The considerable ownership by individual investors in G1 Therapeutics indicates that...
G1 Therapeutics, Inc.'s (NASDAQ:GTHX) Path To Profitability
Simply Wall St. via Yahoo Finance· 1 year agoWith the business potentially at an important milestone, we thought we'd take a closer look at G1...
Is G1 Therapeutics (NASDAQ:GTHX) Using Too Much Debt?
Simply Wall St. via Yahoo Finance· 2 years agoHoward Marks put it nicely when he said that, rather than worrying about share price volatility,...